Resultado de búsqueda
15 de jun. de 2022 · Libby and Tokgözoğlu discuss the management of atherogenic lipoproteins, notably low-density lipoprotein, with an emphasis on the role of strategies that target PCSK9.
18 de mar. de 2014 · Peter Libby，哈佛大学医学院教授，Brigham and Women’s医院心内科主任，大学心脏病学家协会主席，动脉硬化、循环和基础科学理事会的执行委员会成员，两届美国心脏病学院的同行评审委员会主席。他的主要研究方向是炎症在血管疾病如动脉粥样硬化中的作用。
Peter Libby, MD, is a cardiovascular specialist at Brigham and Women’s Hospital in Boston, Massachusetts, and holds the Mallinckrodt Professorship of Medicine at Harvard Medical School. His areas of clinical expertise include general and preventive cardiology. His current major research focus is the role of inflammation in vascular diseases ...
As a cardiovascular specialist at Brigham and Women’s Hospital in Boston, Massachusetts, Dr. Peter Libby holds the Mallinckrodt Professorship of Medicine at Harvard Medical School. His areas of clinical expertise include general and preventive cardiology, and his current major research focus is the role of inflammation in vascular diseases ...
26 de ene. de 2022 · 目前，他汀虽然仍是降脂治疗的首选。但1月20日，动脉粥样硬化炎症学说开创者、美国哈佛大学医学院Peter Libby博士和欧洲动脉粥样硬化学会（EAS）前任主席Lale Tokgözoğlu教授在《欧洲心脏杂志》上发文指出，降脂治疗即将迎来靶向治疗新时代。
1 de sept. de 2020 · This essay explores the hypothesis that COVID-19, particularly in the later complicated stages, represents an endothelial disease. Cytokines, protein pro-inflammatory mediators, serve as key danger signals that shift endothelial functions from the homeostatic into the defensive mode. The endgame of COVID-19 usually involves a cytokine storm, a ...
28 de feb. de 2022 · When “Braunwald’s Heart Disease” debuted in 1980, Peter Libby, MD, had just finished his training at the old Peter Bent Brigham Hospital.His chief, Eugene Braunwald, MD, the founding editor of what would become the leading textbook of cardiovascular medicine, gave Dr. Libby a copy at the author’s price with one provision: He had to review and provide notes on the pacemakers chapter.
